ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · Real-Time Price · USD
5.07
+0.36 (7.64%)
At close: Nov 20, 2024, 4:00 PM
4.860
-0.210 (-4.14%)
After-hours: Nov 20, 2024, 6:22 PM EST
7.64%
Market Cap 2.69M
Revenue (ttm) n/a
Net Income (ttm) -9.00M
Shares Out 531.19K
EPS (ttm) -131.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 221,263
Open 5.06
Previous Close 4.71
Day's Range 4.48 - 6.18
52-Week Range 4.01 - 4,882.50
Beta 0.74
Analysts Strong Buy
Price Target 14,000.00 (+276,034.12%)
Earnings Date Nov 15, 2024

About NDRA

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was in... [Read more]

Sector Healthcare
IPO Date May 9, 2017
Employees 21
Stock Exchange NASDAQ
Ticker Symbol NDRA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for NDRA stock is "Strong Buy" and the 12-month stock price forecast is $14,000.0.

Price Target
$14,000.0
(276,034.12% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months en...

5 days ago - Business Wire

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a poster titled “Noninvasive...

8 days ago - Business Wire

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office has issued to ENDRA a n...

14 days ago - Business Wire

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the activation of a post market clinical study and firs...

4 weeks ago - Business Wire

Data I/O And 2 Other Stocks Under $5 Executives Are Buying

The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Other symbols: DAIO
2 months ago - Benzinga

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that on August 27, 2024, the Com...

3 months ago - Business Wire

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2024 Earnings Conference Call August 22, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Alexander Tokman - Acting CEO Ziad Rouag...

3 months ago - Seeking Alpha

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), reports financial results for the three and six ...

3 months ago - Business Wire

ENDRA Life Sciences Announces Reverse Stock Split

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it will implement...

3 months ago - Business Wire

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it will host a co...

3 months ago - Business Wire

ENDRA Life Sciences Announces Leadership Changes

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced its Board of Directors...

3 months ago - Business Wire

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will re...

3 months ago - Business Wire

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that ...

6 months ago - Business Wire

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best will host a complimentary webinar titled “The Case for Engaging Defense Counsel Pre-Lawsuit,” on June 25, 2024, at 2:00 p.m. ET. In this webinar, s...

6 months ago - Business Wire

ENDRA Provides Update Following In-person Meeting with FDA

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced that it has completed what it consider...

6 months ago - Business Wire

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q1 2024 Earnings Call Transcript May 14, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Exec...

6 months ago - Seeking Alpha

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three m...

6 months ago - Business Wire

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will re...

7 months ago - Business Wire

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of five new patents, incl...

7 months ago - Business Wire

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

8 months ago - Seeking Alpha

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three mo...

8 months ago - Business Wire

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will re...

8 months ago - Business Wire

ENDRA Life Sciences Installs First TAEUS System in the UK

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it has installed a TAEUS liver sy...

9 months ago - Business Wire

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), welcomes the adoption of the ICD-10 K76.0 code f...

9 months ago - Business Wire

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new patents, inc...

10 months ago - Business Wire